Skip to main content
. 2013 Jan 9;8(1):e53137. doi: 10.1371/journal.pone.0053137

Figure 7. Transcription activity changes of human TnIc promoters in the presence of compound 3.

Figure 7

(a) Transcription activity of constructed human TnIc promoters in the absence of compound 3. (b) Transcription activity of constructed human TnIc promoters in the presence of 100 µM compound 3. Columns in a and b are normalised to the luciferase transcription level of the wild type control 6MNS(E)-WT in the absence of ligand. (c) Dose-response curves of compound 3 with different luciferase vectors. (**P<0.01, *P<0.05 and ♯P≥0.05, no significant differences compared to WT construct).